Transaction DateRecipientSharesTypePriceValue
8th January 2021Management, Llc Newtyn62,846Open or private purchase$4.66$293,050.90
7th January 2021Management, Llc Newtyn16,939Open or private purchase$4.73$80,189.23
6th January 2021Management, Llc Newtyn67,310Open or private purchase$4.63$311,577.99
4th January 2021Management, Llc Newtyn60,112Open or private purchase$4.40$264,613.02
4th January 2021Management, Llc Newtyn60,112Open or private sale$4.40$264,432.69
30th September 2020Management, Llc Newtyn3,850,000Disposition due to a tender of shares in a change of control transaction$0.00
30th September 2020Asset Management Lp Weiss801,424Disposition due to a tender of shares in a change of control transaction$12.00$9,617,088.00
29th September 2020Asset Management Lp Weiss100,000Open or private sale$12.74$1,273,580.00
16th June 2020Patrick K. Lucy770Open or private sale$10.23$7,873.33
16th June 2020Patrick K. Lucy770Exercise of derivative$3.38$2,602.60
Pfenex
Pfenex logo

Pfênex, Inc. engages in the research, development, and commercialization of pharmaceutical products. The company was founded on November 19, 2009 and is headquartered in San Diego, CA.


Ticker: PFNX
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1478121
Employees: 81
Exchange: NYSE American
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals
News